A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04088058 |
|
Recruitment Status : Unknown
Verified March 2020 by Gwo Xi Stem Cell Applied Technology Co., Ltd..
Recruitment status was: Recruiting
First Posted : September 12, 2019
Last Update Posted : March 5, 2020
|
Sponsor:
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Information provided by (Responsible Party):
Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | October 31, 2021 |
| Estimated Study Completion Date : | June 30, 2022 |